Related Experiment Video
Updated: Aug 29, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship
Mohamad S Alabdaljabar1, Urshila Durani2, Carrie A Thompson2
1Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abstract:
The number of non-Hodgkin lymphoma (NHL) survivors is increasing. With the advancement of NHL therapies, it is crucial to focus on the challenges these survivors may face. Three main categories are to be considered in NHL survivorship, including quality of life and uncertainty about the future, possible physical health complications (including cardiovascular disease, infertility, and subsequent neoplasms), and the impact of novel NHL treatments and their potential complications. The latter includes CAR T-cell therapy, monoclonal antibodies, checkpoint inhibitors, and hematopoietic stem cell transplantation. In this report, we aim to shed the light on these aspects and to discuss survivorship care plan for NHL.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Comparing the Survival Analysis of Two or More Groups
Kaplan-Meier Approach
Assumptions of Survival Analysis
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...

